Company / Cost of Revenue
Exelixis Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$83.7M
FY2025
5-year range
$33.1M / $83.7M
FY2021-FY2025
Trend
+9.8%
vs FY2024
Sector context
#46 of 85
Health Care
What the data says
At $84M, Exelixis's cost of revenue ranks #40 of 85 in the Health Care sector. Cost of Revenue has increased for 4 consecutive years, from $33M in FY2021 to $84M in FY2025.
Based on SEC 10-K filings.
$84M in FY2025 with a 5-year CAGR of +18.2%.
Increased from $73M to $84M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +32.1%
- 5-Year CAGR
- +18.2%
- 10-Year CAGR
- -
Sector benchmark
#40 of 85 in Health CareTop 46% of 85This company $83.7M Sector average $2.0B
▼
-95.8% below sector average
Key checks
Key Insights
- Exelixis's cost of revenue has grown for 4 consecutive years.
- 5-year CAGR of +18.2%, indicating consistent growth.
- In FY2025, cost of revenue increased 9.8% year-over-year.
- Ranks #46 out of 85 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $83.7M | +9.8% |
| FY2024 | $76.2M | +5.1% |
| FY2023 | $72.5M | +100.0% |
| FY2022 | $36.3M | +9.6% |
| FY2021 | $33.1M | -8.8% |
| FY2020 | $36.3M | +9.6% |
| FY2019 | $33.1M | +405.1% |
| FY2018 | $6.6M | -56.5% |
| FY2017 | $15.1M | +129.9% |
| FY2016 | $6.6M | +68.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026